ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372950 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372950; 2) Community: the network communities that were significantly associated with the response to NSC 372950; 3) Molecule: the relationships between components within communities and NSC 372950; 4) MDR: the compounds that were significantly associated with the NSC 372950.

NSC Compound Enrichment Correlation
NSC 6926 Null 0.0352028253287042 0.35449389
NSC 694619 Null 0.0352028253287042 0.33621772
NSC 699934 Null 0.0352028253287042 0.13138672
NSC 709974 Null 0.0352028253287042 0.41560013
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.14101952
NSC 720134 Null 0.0352028253287042 0.17141058
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0352028253287042 -0.10273447
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.41844736
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0352028253287042 0.075808241
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0352028253287042 0.37029488
Total:169  Current:129    [First] [Prev] [Next] [Last]